University of Texas Southwestern in Dallas, Texas. Her clinical practice has focused on head and neck cancer, lymphoma and hematologic malignancies, CNS malignancies, lung cancer, and breast cancer. However, she is board certified and experienced in treating all disease sites. She has clinical research experience in several disease sites as well, including head and neck cancer, glioblastoma, esophageal cancer, cutaneous lymphoma, and lung cancer. Patient care is her passion, and she enjoys working with patients on a daily basis. She is a strong believer in patient education and making sure patients understand their disease and treatment options. Based on her experience developing clinical trials at Stanford, she is developing an academic program focused on the conduct of clinical trials as well as patient and physician decision-making regarding clinical trials. Her goal is to develop tools to improve clinical trial enrollment through medical team communication as well as patient and physician education.

Dr. Shah is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Breast Cancer, and Pleuropulmonary Blastoma.

She is actively involved in clinical research, co-authoring 56 peer reviewed articles and participating in 4 clinical trials. Dr. Shah is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in CA

Hospital Affiliations

University Of Michigan Health System

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance

Find your insuranceClose

Accepted insurance plans:

Aetna

Anthem BCBS

Blue Cross Blue Shield

Cigna

Health Alliance Plan

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D

Humana

HMO
INDEMNITY
POS
PPO

Managed Medicaid

OTHER MANAGED MEDICAID

Medicaid

OTHER MEDICAID
STATE MEDICAID

Meridian Choice

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D

Priority Health

Spectrum Priority Health

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
OTHER COMMERCIAL

UnitedHealthcare

Walgreens

MEDICARE DISCOUNT CARD
MEDICARE PDP
OTHER MEDICARE

Wellcare

EPO
HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER MEDICARE
OTHER MEDICARE PART D

View 9 Less Insurance Carriers -

Locations

Brighton Center for Specialty Care
7500 Challis Rd, Entrance1, Level 1, Brighton, MI 48116

Call: 734-647-8902

Other Locations

Radiation Oncology
1500 E Medical Center Dr, Floor B2 C490, Ann Arbor, MI 48109

Additional Areas of Focus

Dr. Shah has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Breast Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features

Enrollment Status: Recruiting

Publish Date: August 24, 2026

Intervention Type: Procedure, Drug, Radiation, Biological

Study Drugs: Carboplatin, Cisplatin, Pembrolizumab

Study Phase: Phase 2

Phase I Trial of BAY 1895344 ATR Inhibitor Combined With Stereotactic Body Radiation Therapy and Pembrolizumab for Recurrent Head and Neck Squamous Cell Carcinoma

Enrollment Status: Active_not_recruiting

Publish Date: August 21, 2026

Intervention Type: Other, Procedure, Drug, Biological, Radiation

Study Drugs: Elimusertib, Pembrolizumab

Study Phase: Phase 1

A Randomized Study of Topical Dilute Hypochlorite (Modified Dakin's Solution) Treatment for the Prevention of Radiation Dermatitis in Head and Neck Cancer

Enrollment Status: Completed

Publish Date: January 30, 2024

Intervention Type: Drug, Other

Study Phase: Phase 3

A Pilot Study of Perfusion CT for Lung Tumors Treated With Stereotactic Ablative Radiation Therapy (SABR)

Enrollment Status: Completed

Publish Date: November 22, 2023

Intervention Type: Drug, Radiation, Device

Study Drug: Isovue-200

Study Phase: Phase 1

View 3 Less Clinical Trials

56 Total Publications

Combined Positive Score and Cost-Effectiveness of Perioperative Pembrolizumab for Head and Neck Cancer.

Journal: JAMA otolaryngology-- head & neck surgery

Published: August 06, 2026

View All 56 Publications

Similar Doctors

Expertise in

conditions

Dr. Daniel R. Wahl

Radiation Oncology

Expertise in

conditions

Dr. Daniel R. Wahl

Radiation Oncology

Referral may be required

University Hospital

1500 E Medical Center Dr, Floor B2 C490,

Ann Arbor, MI

(18.4 miles away)

734-936-4300

Languages Spoken:

English

See accepted insurances

Accepting New Patients

Offers Telehealth

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Brain Tumor, and Glioma. Dr. Wahl is currently accepting new patients.

Expertise in

conditions

Dr. Inga S. Grills

Radiation Oncology

Expertise in

conditions

Dr. Inga S. Grills

Radiation Oncology

Referral may be required

Before you request

Rose Cancer Treatment Center

3577 West 13 Mile Road, Suite Ll,

Royal Oak, MI

(30.9 miles away)

248-551-5490

Languages Spoken:

English

See accepted insurances

Accepting New Patients

Offers Telehealth

Inga Grills is a Radiation Oncologist practicing medicine in Royal Oak, Michigan. Dr. Grills is highly rated in 41 conditions, according to our data. Her clinical expertise encompasses Arteriovenous Malformation, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Gamma Knife Radiosurgery. Dr. Grills is board certified in American Board Of Radiology. Dr. Grills is currently accepting new patients.

Expertise in

conditions

Dr. Prakash Chinnaiyan

Radiation Oncology

Expertise in

conditions

Dr. Prakash Chinnaiyan

Radiation Oncology

Referral may be required

Before you request

Rose Cancer Treatment Center

3577 West 13 Mile Road, Suite Ll,

Royal Oak, MI

(30.9 miles away)

248-551-5490

Languages Spoken:

English

See accepted insurances

Accepting New Patients

Prakash Chinnaiyan is a Radiation Oncologist practicing medicine in Royal Oak, Michigan. Dr. Chinnaiyan is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Gamma Knife Radiosurgery. Dr. Chinnaiyan is board certified in American Board Of Radiology. Dr. Chinnaiyan is currently accepting new patients.

VIEW MORE Radiation Oncologists

Frequently Asked Questions about Dr. Jennifer L. Shah

How do I make an appointment with Dr. Jennifer L. Shah?

You can book an appointment with Dr. Jennifer L. Shah by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jennifer L. Shah a top-rated expert for Throat Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jennifer L. Shah is classified as an Distinguished expert for Throat Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jennifer L. Shah specialize in?

While Dr. Jennifer L. Shah is a Radiation Oncology, they have specific expertise in Throat Cancer, Laryngeal Cancer, and Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Jennifer L. Shah participate in research or clinical trials?

Yes. Dr. Jennifer L. Shah has published 56 articles and abstracts on conditions like Throat Cancer. You can view a list of Dr. Jennifer L. Shah's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jennifer L. Shah accept my insurance?

Dr. Jennifer L. Shah accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shah's expertise for a condition

ConditionClose